36 - PILOT STUDY OF EXPLOITING ABDOMINAL SOUND FOR EARLY MEAL ONSET DETECTION
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
37 - CASE REPORT ON THE PERFORMANCE OF LONG-TERM USAGE OF AN INTEGRATED BIHORMONAL ARTIFICIAL PANCREAS IN DAILY LIFE
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
38 - THE BETA-AIR DEVICE, A BIOARTIFICIAL PANCREAS (BAP) FOR LONG-TERM MAINTENANCE OF NORMOGLYCEMIA IN DIABETIC ANIMAL MODELS AND HUMAN; AN UPDATE.
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
39 - KINETICS OF CONTINUOUSLY MEASURED INTERSTITIAL VERSUS VENOUS LACTATE FOLLOWING HIGH INTENSITY EXERCISE IN ADULTS WITH TYPE 1 DIABETES
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
40 - CLOSING THE LOOP FOR DIABETES: OUR CLINICAL EXPERIENCE WITH THE USE OF ARTIFICIAL PANCREAS SYSTEM ALMOST ELIMINATING HYPOGLYCEMIAS.
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
42 - USE OF THE ULTRA-RAPID INSULIN FIASP IN THE ILET BIONIC PANCREAS
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
43 - PERFORMANCE OF THE DIABELOOP ARTIFICIAL PANCREAS IS NOT CORRELATED TO AGE, BODY WEIGHT, SEX, OR EXERCISE
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
44 - INTRA-INDIVIDUAL VARIABILITY IN SUBCUTANEOUS INSULIN ABSORPTION DURING HYBRID CLOSED-LOOP MEAL STUDY IN YOUTHS WITH TYPE 1 DIABETES: A MODELING ANALYSIS
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
45 - UNANNOUNCED MEAL CHALLENGES IN A PROTECTED FREE LIVING ENVIRONMENT USING THE MINIMED 670G 4.0 SYSTEM
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
46 - INCORPORATION OF INTRAPERITONEAL INSULIN DELIVERY IN THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR: MODEL PREDICTIVE CONTROL IN SILICO TRIALS VS THE SUBCUTANEOUS ROUTE
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
ARTIFICIAL PANCREAS
49 - REAL-WORLD USE OF IQCAST HYPOGLYCEMIA PREDICTION FEATURE IN THE GUARDIAN™ CONNECT SYSTEM AND ITS IMPACT ON CLINICAL OUTCOMES
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
CLINICAL DECISION SUPPORT SYSTEMS/ADVISORS
50 - EFFICACY AND SAFETY OF THE PATIENT EMPOWERMENT THROUGH PREDICTIVE PERSONALISED DECISION SUPPORT (PEPPER) SYSTEM: AN OPEN-LABEL RANDOMISED CONTROLLED TRIAL
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Session Name
CLINICAL DECISION SUPPORT SYSTEMS/ADVISORS